Embecta Corp (EMBC) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Embecta Corp (EMBC) has a cash flow conversion efficiency ratio of -0.068x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($41.80 Million) by net assets ($-612.70 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see EMBC company net worth for the company's overall valuation and market capitalisation.
Embecta Corp - Cash Flow Conversion Efficiency Trend (2019–2025)
This chart illustrates how Embecta Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Embecta Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Embecta Corp ranked by their cash flow conversion efficiency. Explore how high is Embecta Corp's earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
NICE Holdings Co. Ltd
KO:034310
|
0.070x |
|
Bpost NV
BR:BPOST
|
0.252x |
|
XAI Octagon Floating Rate & Alternative Income Term Trust
NYSE:XFLT
|
0.040x |
|
Onity Group Inc.
NYSE:ONIT
|
-3.192x |
|
Orbit Technologies Ltd
TA:ORBI
|
-0.056x |
|
BMTC Group Inc
TO:GBT
|
0.006x |
|
INTERGRATED DIA.H DL 025
F:8I8
|
0.096x |
|
Taeyoung Engineering & Construction Co.,Ltd.
KO:009415
|
-0.073x |
Annual Cash Flow Conversion Efficiency for Embecta Corp (2019–2025)
The table below shows the annual cash flow conversion efficiency of Embecta Corp from 2019 to 2025. View latest Embecta Corp stock price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | $-651.20 Million | $191.70 Million | -0.294x | -508.80% |
| 2024-09-30 | $-738.30 Million | $35.70 Million | -0.048x | +41.31% |
| 2023-09-30 | $-821.70 Million | $67.70 Million | -0.082x | +82.18% |
| 2022-09-30 | $-891.40 Million | $412.20 Million | -0.462x | -160.24% |
| 2021-09-30 | $594.00 Million | $456.00 Million | 0.768x | -11.91% |
| 2020-09-30 | $572.00 Million | $498.50 Million | 0.872x | +6.82% |
| 2019-09-30 | $619.00 Million | $505.00 Million | 0.816x | -- |
About Embecta Corp
Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors… Read more